Toronto, Ontario–(Newsfile Corp. – November 9, 2021) – West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTCQB: MMJFD) (“West Island” or the “Company”) is pleased to announce that West Island subsidiary RoyalMax Biotechnology Canada Inc. D.B.A West Island Culture has forwarded its first shipment of OUESTTM brand premium Montreal cannabis to the Province of Ontario. The company has signed a Master Supply Agreement with the Ontario Cannabis Retail Corporation, doing business as the Ontario Cannabis Store (the “OCS”), which is the sole wholesale distributor of cannabis for the province.
West Island CEO, Boris Ziger states, “For our first entry of OUESTTM brand of premium craft cannabis into Ontario we have chosen ‘Sweet Demon’, a super premium product that has become an instant classic. We hope to give Ontario a taste of things to come in the future as we continue to introduce new and exciting products in the coming months.”
Management continues to aggressively expand the Company’s commercial and production footprint to additional Canadian provinces. The Company has cancelled 17,500,000 previous granted management and director’s stock options.
About West Island
West Island is a multi-faceted, innovative company in the Quebec cannabis space. Its subsidiary, RoyalMax Biotechnology Canada Inc. is a Dorval, Quebec based Health Canada Licence Holder with standard cultivation licence, standard processing, medical sales and sales licences. The Company continues to work with Yunify Natural Technologies, a Quebec based health and personal care research and innovation company to develop proprietary products for West Island including topicals and ionic mists. Through its acquisition of Trichome Treats, an award winning chocolatier, the Company intends on introducing edibles into the West Island product mix.
For more information on West Island Brands please visit the website at: westislandbrands.com.
On behalf of the Board of Directors
WEST ISLAND BRANDS INC.
Boris Ziger, CEO & Chairman
Disclaimer for Forward-Looking Information
Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation’s filings with the Canadian securities regulators, which filings are available at www.sedar.com.
This news release contains statements about the Company’s information that may be made available on the S&P Capital IQ Corporation Records Listing Program and the business of Matica that are forward-looking in nature and as a result, are subject to certain risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them as actual results may differ materially from the forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek Safe Harbor.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/102526